Home Newsfeeds Telsey Advisory Group Maintains Outperform on Five Below, Raises Price Target to $230

Telsey Advisory Group Maintains Outperform on Five Below, Raises Price Target to $230

Telsey Advisory Group analyst Joseph Feldman maintains Five Below (NASDAQ:FIVE) with a Outperform and raises the price target from $195 to $230.

byBenzinga Newsdesk

March 8, 2023

1 minute read

Telsey Advisory Group analyst Joseph Feldman maintains Five Below (NASDAQ:FIVE) with a Outperform and raises the price target from $195 to $230.

Wells Fargo Maintains Equal-Weight on Canadian Solar, Lowers Price Target to $33

By Benzinga Newsdesk

January 6, 8:56 AM

Wells Fargo analyst Praneeth Satish maintains Canadian Solar (NASDAQ:CSIQ) with a Equal-Weight and lowers the price target from $38 to $33.

CSIQ

Inhibrx Announces $200M Private Placement Financing; In The PIPE, Co Is Selling An Aggregate Of 3,621,314 Shares Of Its Common Stock At A Price Of $19.35 Per Share

By Happy Mohamed

August 29, 9:03 AM

Inhibrx, Inc. (NASDAQ:INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, announced today

INBX

Important Biotech Catalysts For September 15, 2022 – End Of The Day Summary

By Ragothaman Srinivasan

September 15, 6:47 PM

Pfizer (NYSE:PFE) announced positive top-line results from the pivotal Phase 3 trial assessing the safety, tolerability, and immunogenicity…

ALNY

Alibaba, Tencent Fined By Chinese Regulator Over Non-Compliance With Anti-Monopoly Rules

By Navdeep Yadav

July 11, 5:55 AM

China's State Administration for Market Regulation (SAMR) on Sunday imposed fines on technology giants Alibaba Group Holdings (NYSE: BABA) and Tencent Holdings (OTC: TCEHY), among other firms,

BABA

Telsey Advisory Group Maintains Outperform on Five Below, Raises Price Target to $230

Related Posts

Wells Fargo Maintains Equal-Weight on Canadian Solar, Lowers Price Target to $33

Inhibrx Announces $200M Private Placement Financing; In The PIPE, Co Is Selling An Aggregate Of 3,621,314 Shares Of Its Common Stock At A Price Of $19.35 Per Share

Important Biotech Catalysts For September 15, 2022 – End Of The Day Summary

Alibaba, Tencent Fined By Chinese Regulator Over Non-Compliance With Anti-Monopoly Rules